Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04571203 · ClinicalTrials.gov registry record · Phase 1
Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
A Phase 1 study, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT04571203: Recruiting Phase 1 study, sponsored by Stanford University.
NCT04571203 is a Phase 1 study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04571203, a Phase 1 study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single arm phase 1 non randomized dose finding study for safety, feasibility and efficacy of deceased donor vertebral body (VB) marrow cell infusion and kidney transplantation.
Interventions
- BIOLOGICAL Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-06 |
| Est. Completion | 2029-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04571203
The ClinicalTrials.gov registry entry for NCT04571203 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combined Deceased Donor Kidney and Hematopoietic Cell Transplants is the first listed.
NCT04571203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04571203 about?
NCT04571203 is a clinical study titled "Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment". This is a single arm phase 1 non randomized dose finding study for safety, feasibility and efficacy of deceased donor vertebral body (VB) marrow cell infusion and kidney transplantation.
What is the current status of trial NCT04571203?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2022-05-06. Estimated completion is 2029-10-01.
What interventions are being tested in trial NCT04571203?
The interventions under investigation include: Combined Deceased Donor Kidney and Hematopoietic Cell Transplants (BIOLOGICAL).
Who is sponsoring clinical trial NCT04571203?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.